Expression of versican and its clinical significance in gastric carcinoma

Chinese Journal of Pathology

Volumn 43, Issue 7, 2014, Pages 473-477

  Miling, Yang ^a   Lifeng, Wang ^a   Jinhua, Yang ^a   Guangying, Yang ^a  

^a People's Hospital of Zhengzhou   (China)

Author keywords

Microvessels; Neovascularization, pathologic; Stomach neoplasms; Vascular endothelial growth factors

Indexed keywords

CD34 ANTIGEN; TUMOR PROTEIN; VASCULOTROPIN A; VERSICAN;

FIBROBLAST; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; STOMACH; STOMACH TUMOR; VASCULARIZATION;

ANTIGENS, CD34; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; STOMACH; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VERSICANS;

EID: 84905644420     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2014.07.010     Document Type: Article

References (16)

1. Voutilainen K, Anttila M, Sillanp S, et al. Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis[J]. Int J Cancer, 2003, 107(3):359-364.
2. Volm M, Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer[J]. Int J Cancer, 1997, 74(1):64-68.
3. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma[J]. J Natl Cancer Inst, 1992, 84(24):1875-1887.
4. Theocharis AD, Tsara ME, Papageorgacopoulou N, et al. Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition[J]. Biochim Biophys Acta, 2000, 1502(2):201-206.
5. Theocharis AD. Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin [J]. Biochim Biophys Acta, 2002, 1588(2):165-172.
6. Skandalis SS, Theocharis AD, Theocharis DA, et al. Matrix proteoglycans are markedly affected in advanced laryngeal squamous cell carcinoma[J]. Biochim Biophys Acta, 2004, 1689(2):152-161.
7. Ricciardelli C, Sakko AJ, Ween MP, et al. The biological role and regulation of versican levels in cancer[J]. Cancer Metastasis Rev, 2009, 28(1-2):233-245.
8. Brown LF, Cuidi AJ, Schnitt SJ, et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast[J]. Clin Cancer Res, 1999, 5(5):1041-1056.
9. Edwards U. Proteoglycans in prostate cancer [J]. Nat Rev Urol, 2012, 9(4):196-206.
10. Ghosh S. Albitar L, Le Baron R, et al. Up-regulation of stromal versican expression in advanced stage serous ovarian cancer [J]. Gynecol Oncol, 2010, 119(1):114-120.
11. Seo HY, Park JM, Park KH, et al. Prognostic significance of serum vascular endothelial growth factor per platelet count in unresectable advanced gastric cancer patients[J]. Jpn J Clin Oncol, 2010, 40 (12) 1147-1153.
12. Zheng PS, Wen J, Ang LC, et al. Versican/PG-M G3 domain promotes tumor growth and angiogenesis [J]. FASEB J, 2004, 18(6):754-756.
13. Sakko AJ, Ricciardelli C, Mayne K, et al. Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor betal [J]. Cancer Res, 2001, 61(3)::926-930.
14. Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell biology[J]. Curr Opin Cell Biol, 2002, 14(5):617-623.
15. Syrokou A, Tzanakakis GN, Hjerpe A, et al. Proteoglycans in human malignant mesothelioma. Stimulation of their synthesis induced by epidermal, insulin and platelet-derived growth factors involves receptors with tyrosine kinase activity [J]. Biochimie, 1999, 81(7):733-744.
16. Cattaruzza S, Schiappacassi M, Ljungberg-Rose A, et al. Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro [J]. J Biol Chem, 2002, 277(49):4762647635.